IL2 and neoplasm: In the past few years, engineered MSCs have been widely studied for the delivery of therapeutic cytokines including interleukin-2 (IL-2)15, IL-1216, interferon-β (IFN-β)17, all of which exhibited efficient anti-tumor effects.